U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy

US corporate bond market issuance set to slow amid market volatility By Matt Tracy and Davide Barbuscia Aug 6 (Reuters) - Some corporate bond issuers are expected to delay sales this week, after market volatility caused investors to trim corporate bond holdings in favor of safer U.S. Treasuries, according to bond market participants. Weaker-than-expected employment and manufacturing growth data last week have stoked recession fears, hitting stocks and causing investors to seek safety in U.S.

BRIEF-Eversource Q2 EPS USD 0.95 Vs. IBES Estimate USD 0.96 Jul 31 (Reuters) - Eversource Q2 net income USD 335.3 million vs. IBES estimate USD 344.8 million.

MORNING BID AMERICAS-BOJ hikes with Fed ahead, Big Tech flubs A look at the day ahead in U.S. and global markets from Mike Dolan By any standards of an already busy year, markets are digesting an awful lot of information in a very short space of time - with a Bank of Japan interest rate rise and Microsoft earnings disappointment the latest servings on the final day of July.

U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics July 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Edwards Lifesciences, National Bank Holdings and Sage Therapeutics, on Thursday. HIGHLIGHTS * Edwards Lifesciences Corp EW.N : JP Morgan cuts to neutral from overweight * National Bank Holdings Corp NBHC.N : Piper Sandler cuts to neutral from overweight * Sage Therapeutics Inc S

UPDATE 1-NY governor announces start of construction on Sunrise Wind project Adds more details after first paragraph July 17 (Reuters) - New York Governor Kathy Hochul announced the start of construction on Sunrise Wind, a 924-megawatt offshore wind project developed by Oersted ORSTED.CO , the New York State Energy Research and Development Authority (NYSERDA) said on Wednesday.

UPDATE 1-New York finalizes offshore wind contracts for Equinor, Orsted projects Adds dateline, changes sourcing to N.Y. officials, adds detail, background STOCKHOLM, June 4 (Reuters) - The New York State Energy Research and Development Authority (NYSERDA) said on Tuesday it had finalized contracts for Equinor's EQNR.OL Empire Wind 1 and Orsted's ORSTED.CO and Eversource's ES.N Sunrise Wind offshore wind projects.

New York finalizes offshore wind contracts for Equinor, Orsted projects June 4 (Reuters) - New York officials on Tuesday said the state had finalized contracts for Equinor's EQNR.OL Empire Wind 1 and Orsted ORSTED.CO and Eversource's ES.N Sunrise Wind offshore wind projects. The New York State Energy Research and Development Authority said in a statement the average bill impact for residential customers over the life of the projects will be about $2.09 per month.

Vineyard Offshore and Energy New England partner for clean energy May 15 (Reuters) - U.S. offshore wind developer Vineyard Offshore (VO) and municipal light plant cooperative Energy New England (ENE) announced a partnership on Wednesday to explore clean energy options for Massachusetts if the state awards them contracts. VO proposed the 1,200 megawatt (MW) Vineyard Wind 2 project in March in response to solicitations from Massachusetts, Connecticut and Rhode Island, as per the release.